Search

Displaying results 3831 - 3840 of 5924 in total
  1. Drug

    Tecalcet

    go.drugbank.com/drugs/DB20329
    Experimental

    Tecalcet has a monoisotopic molecular weight of 303.14 Da.

  2. Drug

    Lirodegimod

    go.drugbank.com/drugs/DB21675
    Experimental

    Lirodegimod has a monoisotopic molecular weight of 1256.45 Da.

  3. Drug

    Segatroxaban

    go.drugbank.com/drugs/DB21678
    Experimental

    Segatroxaban has a monoisotopic molecular weight of 567.14 Da.

  4. Drug

    Fanregratinib

    go.drugbank.com/drugs/DB21688
    Experimental

    Fanregratinib has a monoisotopic molecular weight of 508.24 Da.

  5. Drug

    Ilantimod

    go.drugbank.com/drugs/DB21742
    Experimental

    Ilantimod has a monoisotopic molecular weight of 387.11 Da.

  6. Drug

    Atomoxetine

    go.drugbank.com/drugs/DB00289
    ApprovedInvestigational

    [A178090] Atomoxetine has been shown to specifically increase NA and DA within the prefrontal cortex, but not in the nucleus accumbens (NA) or striatum. … [A18262] This is beneficial in the treatment of ADHD as DA activation in the subcortical NA and striatum is associated with many stimulant-associated side effects and an increase in abuse potential, which

    Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2D6 Substrates
  7. Drug

    Galamustine

    go.drugbank.com/drugs/DB21062
    Experimental

    Galamustine has a monoisotopic molecular weight of 303.06 Da.

  8. Drug

    Barucainide

    go.drugbank.com/drugs/DB19585
    Experimental

    Barucainide has a monoisotopic molecular weight of 354.23 Da.

  9. Drug

    Eptazocine

    go.drugbank.com/drugs/DB19670
    Experimental

    Eptazocine has a monoisotopic molecular weight of 231.16 Da.

  10. Drug

    Suricainide

    go.drugbank.com/drugs/DB19705
    Experimental

    Suricainide has a monoisotopic molecular weight of 369.21 Da.